All current vaccines require constant updating to keep up with virus mutations. However, they are unlikely to offer the same reliable protection

Real-world data showed that bivalent messenger RNA vaccines against SARS-CoV-2 provided “significant additional protection”

During the COVID-19 pandemic, the volume of services that specialists provide to people via the Internet has increased dramatically around the world

A new Japanese study of highly purified eicosapentaenoic acid (EPA; icosapent ethyl) has suggested a possible benefit in reducing adverse cardiovascular events in patients with chronic coronary artery disease taking statins.

This vaccine will also be directed at other strains

To defeat HIV by 2030, England has bet on the modern antiretroviral therapy and treatment coverage